The effect of zidovudine on antigen levels in HIV infection
Glaser, V.
New York State Journal of Medicine 88(5): 284-285
1988
ISSN/ISBN: 0028-7628 PMID: 3164101 Document Number: 324651
Document emailed within 1 workday
Related Documents
Mulder, J.W.; Lange, J.M.; de Wolf, F.; Houweling, J.T.; Bakker, M.; Coutinho, R.A.; Goudsmit, J. 1990: Serum p24 antigen levels in untreated and zidovudine-treated HIV-1 infected subjects Netherlands Journal of Medicine 37(1-2): 4-10Dolin, R.; Amato, D.A.; Fischl, M.A.; Pettinelli, C.; Beltangady, M.; Liou, S.H.; Brown, M.J.; Cross, A.P.; Hirsch, M.S.; Hardy, W.D. 1995: Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group Archives of Internal Medicine 155(9): 961-974
Ferrazin, A.; De Maria, A.; Gotta, C.; Mazzarello, G.; Canessa, A.; Ciravegna, B.; Cirillo, C.; Melica, F.; Terragna, A. 1993: Zidovudine therapy of HIV-1 infection during pregnancy: assessment of the effect on the newborns Journal of Acquired Immune Deficiency Syndromes 6(4): 376-379
Bass, H.Z.; Hardy, W.D.; Mitsuyasu, R.T.; Taylor, J.M.; Wang, Y.X.; Fischl, M.A.; Spector, S.A.; Richman, D.D.; Fahey, J.L. 1992: The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals Journal of Acquired Immune Deficiency Syndromes 5(3): 215-221
Dickover, R.E.; Garratty, E.M.; Herman, S.A.; Sim, M.S.; Plaeger, S.; Boyer, P.J.; Keller, M.; Deveikis, A.; Stiehm, E.R.; Bryson, Y.J. 1996: Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load JAMA 275(8): 599-605
Moeller, A.A.; Oechsner, M.; Backmund, H.C.; Popescu, M.; Emminger, C.; Holsboer, F. 1991: Self-reported sleep quality in HIV infection: correlation to the stage of infection and zidovudine therapy Journal of Acquired Immune Deficiency Syndromes 4(10): 1000-1003
Plachý, V.; Turková, M.; Skalaská, H.; Horácek, J. 1976: The relationship between antigen stimulation by cytomegalovirus infection and the immunoglobulin levels in early childhood Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Suppl 19(5): 557-565
Lee, C.M.; Humphrey, P.A.; Aboko-Cole, G.F. 1983: Interaction of nutrition and infection: effect of zinc deficiency on immunoglobulin levels in trypanosoma musculi infection Journal of the National Medical Association 75(7): 677-682
Lee, C.M.; Humphrey, P.A.; Aboko-Cole, G.F. 1983: Interaction of nutrition and infection: effect of zinc deficiency on immunoglobulin levels in trypanosoma musculi infection Journal of the National Medical Association 75(7): 677-682
Xu, Z.-Q.; Hua, L.-X.; Qian, L.-X.; Wu, H.-F. 2002: Effect of transrectal prostatic biopsy on serum prostate specific antigen levels Zhonghua Nan Ke Xue 8(5): 341-342
Claasen, J.N. 1988: Decrease in human immunodeficiency virus antigen titer in the cerebrospinal fluid during treatment of AIDS patients with zidovudine Nederlands Tijdschrift Voor Geneeskunde 132(46): 2122-2123
Masquelier, B.; Lemoigne, E.; Pellegrin, I.; Douard, D.; Sandler, B.; Fleury, H.J. 1993: Primary infection with zidovudine-resistant HIV New England Journal of Medicine 329(15): 1123-1124
Régnier, B. 1991: Treatment of HIV infection with zidovudine. the good use of AZT La Revue du Praticien 41(19): 1801-1804
Domaniewski, J.; Balcar-Boroń, A.; Cetnarowski, L.; Wysocki, M.; Sujkowska, R.; Szaflarska, M. 1986: Effect of various factors on the carcinoembryonic antigen and alpha fetoprotein levels of the blood serum of children Pediatria Polska 61(2): 87-92
Mays, D.C.; Dixon, K.F.; Balboa, A.; Pawluk, L.J.; Bauer, M.R.; Nawoot, S.; Gerber, N. 1991: A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats Journal of Pharmacology and Experimental Therapeutics 259(3): 1261-1270
Weverling, G.J.; Lange, J.M.; de Jong, M.D.; de Weerd, H.; Goudsmit, J.; de Wolf, F. 1996: A comparison of serum HIV-1 RNA levels as measured by two quantitative assays in zidovudine-treated, asymptomatic, HIV-infected individuals Antiviral Therapy 1(4): 255-263
Castejón, O.C.; López, A.J.; Pérez Ybarra, L.M.; Castejón, O.C. 2011: Placental villous lesions in HIV-1 infection treated with zidovudine Ginecologia y Obstetricia de Mexico 79(5): 269-279
Lertcheewakarn, P.; Tongprasert, F. 2014: A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 97(4): 361-368
Ruiz-Argüelles, G.J.; Lagunes-Yannelli, B.; Mercado-Díaz, L. 1993: Sequential dideoxycytidine and zidovudine in advanced HIV-1 infection. Phase Ii study Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 45(2): 145-147
1990: Report on zidovudine use in asymptomatic human immunodeficiency virus infection published Clinical Pharmacy 9(6): 406 408